Outlook 2020: One coin to rule them all

Plotting the dollar standard's downfall?

clock • 3 min read

The hype bubble around cryptocurrency, Bitcoin and, to a lesser extent, blockchain, continued to deflate in 2019 and a healthy dose of scepticism and realism broke out.

The idea that you can come late to the crypto party, buy a handful of tokens from start-ups with nothing more to show for themselves than a white paper and make thousands of percent profit has all but vanished. Likewise, Bitcoin's sheen of invincibility has lost its lustre as question marks around the lack of scalability and influence of whale investors and mining pools controlled from China have grown. While blockchain is making headway as a technology for cutting out clunky middle parties and admin, it is increasingly seen as distributed ledger technology (DLT) v1. In other words...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot